Pharmaceutical combination of fingolimod and nabiximols
摘要
This invention is related to single unit formulation of fingolimod or pharmaceutically acceptable salts thereof in combination with nabiximols mostly composed of cannabidiol (CBD) type compound or derivative thereof and tetrahydrocannabinol (THC) type compound or derivative thereof in treatment of multiple sclerosis.
申请公布号
EP2609912(A1)
申请公布日期
2013.07.03
申请号
EP20110196239
申请日期
2011.12.30
申请人
DEVA HOLDING ANONIM SIRKETI
发明人
HAAS, PHILIPP DANIEL;KOC, FIKRET;SIVASLIGIL, RAMAZAN;KANDEMIR, LEVENT;ILHAN, SUNA AYSE